High-Alcohol Oral Formulations Move Into Schedule H1: What G.S.R. 607(E) Means for Manufacturers The Drugs (Tenth Amendment) Rules, 2026 tighten the exemption net around alcohol-based oral medicines — and bring a familiar public health concern squarely into prescription-drug territory. Notification:…
Recent Post
- High-Alcohol Oral Formulations Move Into Schedule H1
- DCC Recommends Comprehensive Regulatory Mechanism to Curb Unapproved Drugs and FDCs
- DCC Recommends Mandatory Public Disclosure of Suspended and Cancelled Drug Licenses
- D&C Amended to Cover Licensing of Stem Cell Products, Gene Therapeutics and Xenografts
- Schedule H2 Expanded: Antimicrobials and Many Other Drugs Now Under Stricter Controls
